A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase III Clinical Study to Evaluate Efficacy and Safety of AYP-101 for the Reduction of Submental Fat in Adults
Latest Information Update: 29 Jul 2025
At a glance
- Drugs Polyenylphosphatidylcholine (Primary)
- Indications Subcutaneous fat disorders
- Focus Therapeutic Use
- Sponsors AMI Pharm
Most Recent Events
- 29 Jul 2025 New trial record